about
Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson diseaseMeta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility lociTranslation initiator EIF4G1 mutations in familial Parkinson diseaseA common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi JewsCharacterisation of the exon structure of the Fanconi anaemia group C gene by vectorette PCRDNAJC13 mutations in Parkinson diseaseCommon genetic variation and susceptibility to partial epilepsies: a genome-wide association studyRare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes.A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteersPopulation-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.An exploration of cognitive subgroups in Alzheimer's diseaseGlucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.ATP13A2 variability in Parkinson disease.PINK1 mutations and parkinsonism.Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.Age at onset in two common neurodegenerative diseases is genetically controlled.LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility.Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study.Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma.Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer.A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine.An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy and other complex diseasesEcoRI RFLP in the Fanconi anaemia complementation group C gene (FACC)Fanconi's anaemia presenting as acute myeloid leukaemia in adulthoodGenetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease
P50
Q24298781-65EF8627-8F0A-4D1B-BC05-439D80DA69D5Q24656799-E342E3D3-5FB1-4312-B2CB-50F45CDB2B19Q28247679-17F8D331-ACA9-48F1-976A-C241CB8CAF93Q28261288-42AD8D7E-6190-475B-B780-59A20E23ECDAQ28269055-7718207C-8963-42F5-942A-7EAB9CD51EFEQ28658355-B3AE18E6-C98A-4453-A75C-BDA78A7517A7Q28943476-542BA797-2147-4861-BD69-0D31255E0AFDQ33847202-A13E0B54-29EF-460A-9518-051AFA174EBCQ33928646-78982EC3-A418-4C23-94C3-B9E26A7AD68FQ33939245-3786FB4A-E7F0-4731-8CB4-D4EBD9B17848Q33993389-DECD0C39-38B7-48E3-9909-566CA24A817AQ34267725-BCB68B0F-8C60-4F77-B17E-C747E7791451Q35525896-65964377-4DA3-4A86-8E99-5E6D314F5940Q37114401-770268D7-012F-41AC-A7F9-9FE93D7AA5ECQ37178950-BC7BC763-0511-417D-AC91-A19482CC19F4Q37183962-004D8E31-FCC9-43CC-B45C-90829E202D2EQ37217180-8B704E45-F22C-49D6-9053-EFC2CA0153A6Q39086510-D80D5FA9-E26D-4E25-A267-986C7A98C4EFQ39102221-4403CA0D-34AD-4A86-8DB9-D8485646405BQ39861154-C1C1D4B8-B146-411D-9D8B-7951D44C318FQ42809598-73821517-F95E-4A8D-850C-AD3AF84A0D41Q46969020-AE1D38E0-8B47-443B-BEA2-7CEE865DC8D6Q47594886-0281C861-D9B4-4FAE-A93C-337A1DD95BF0Q47596541-1218B768-908D-4A80-91EC-2D5751D0B2D1Q48037213-C8D3E41D-CD24-4D8A-B178-9A070CE31B9BQ48529114-C1637E9E-C42D-4F67-857B-4435FD926CAEQ48825579-6A42072A-FFE8-4D9B-8A1E-947E65BA2BC5Q53275072-DD422FC0-45C6-4270-A85C-256CA5E90D3DQ57315904-39EEB404-541A-47DC-86BA-FD53C987927CQ57943884-678BD4AC-6AD3-4308-8AE8-D3B7840EF230Q71397137-967668BB-8BFB-44DC-8CC4-112B1E817F33Q73230025-BDE98A52-4392-47D5-B49D-4B135FDE7334
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1338-1290
@en
name
Rachel A Gibson
@ast
Rachel A Gibson
@en
Rachel A Gibson
@es
Rachel A Gibson
@nl
type
label
Rachel A Gibson
@ast
Rachel A Gibson
@en
Rachel A Gibson
@es
Rachel A Gibson
@nl
altLabel
Gibson RA
@en
R A Gibson
@en
Rachel Gibson
@en
prefLabel
Rachel A Gibson
@ast
Rachel A Gibson
@en
Rachel A Gibson
@es
Rachel A Gibson
@nl
P106
P108
P1153
35519708900
P21
P31
P4012
P496
0000-0002-1338-1290